Mutations in IDH1/2 were also more frequent in the latter group; however, this did not reach statistical significance (30% vs. 20%; p = 0.29).
← all excerpts
Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia.
1
0.2900
0.2900